Joon Lee
Stock Analyst at Truist Securities
(4.87)
# 63
Out of 5,127 analysts
114
Total ratings
66.37%
Success rate
49.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $165.64 | +38.86% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $833.16 | +23.63% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $59.66 | +67.62% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $13.59 | +267.92% | 4 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $360 → $500 | $320.48 | +56.02% | 7 | Dec 8, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $34.72 | +58.41% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $11.91 | +17.55% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $24.20 | +271.90% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $28.17 | +56.19% | 1 | Sep 16, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $463.48 | +5.72% | 4 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $72.07 | +19.33% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $28.75 | +160.87% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $13.44 | +56.25% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $40.97 | +266.12% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $184.30 | +8.52% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $48.83 | +145.75% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.33 | +440.54% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.90 | +132.05% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $24.27 | +48.33% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.78 | +349.44% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $7.69 | +121.07% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.49 | +11.48% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.70 | +386.49% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.18 | +23,711.55% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $50.24 | -32.32% | 1 | Mar 16, 2021 |
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $165.64
Upside: +38.86%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $833.16
Upside: +23.63%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $59.66
Upside: +67.62%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $13.59
Upside: +267.92%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $360 → $500
Current: $320.48
Upside: +56.02%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $34.72
Upside: +58.41%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $11.91
Upside: +17.55%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $24.20
Upside: +271.90%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $28.17
Upside: +56.19%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $463.48
Upside: +5.72%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $72.07
Upside: +19.33%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $28.75
Upside: +160.87%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $13.44
Upside: +56.25%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $40.97
Upside: +266.12%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $184.30
Upside: +8.52%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $48.83
Upside: +145.75%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.33
Upside: +440.54%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.90
Upside: +132.05%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $24.27
Upside: +48.33%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.78
Upside: +349.44%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.69
Upside: +121.07%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.49
Upside: +11.48%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.70
Upside: +386.49%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.18
Upside: +23,711.55%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $50.24
Upside: -32.32%